Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.69 USD | -2.08% | -3.01% | -12.00% |
05-10 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
05-08 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.00% | 1.38B | |
+38.51% | 727B | |
+31.74% | 594B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.44% | 205B | |
-5.97% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Pacira BioSciences : HC Wainwright & Co. Adjusts Price Target on Pacira BioSciences to $86 From $70, Maintains Buy Rating